Skip to main content
Equibles
HSTC logo

HSTC · HST Global, Inc.

Track HSTC — free

Use HSTC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HSTC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.70 At close · Oct 19
Rebalance outlook locked
Market Cap
$29.94M
Shares
42.77M
Volume · Oct 19 100 Avg daily vol (10 sessions) 422

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.70 Open$0.70 Day$0.70–0.70 Available close range$0.01–1.05 Avg vol 30d448 Short int96 · 0.0% of shares · 1.0d Short vol74% DataJan 2020–Oct 2026 Filing10-K · Nov 3

The closing range uses available history since Nov 5, 2025; less than a full year is stored.

Latest documents

2025
2024
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$101,508
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$10,406
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 25.6 · fear Equity put/call 0.59
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +7%
above
Price vs 50-day avg −1%
below
RSI (14) 51
neutral
MACD trend Negative
52-week position 66%
mid-range
Momentum
relative strength
Weak
1-month return +12%
trailing
6-month return −36%
trailing
YTD return −29%
this year
Relative strength −43%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 6453%
annualized · 1-yr
Max drawdown −100%
past year
ATR 45.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+7% Bullish
Price vs 50-day avg
−1% Neutral
RSI (14)
51 Neutral
MACD trend
Negative Bearish
52-week position
66% Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $0 Now $1 · 66% Range high $1
vs 200-day avg +7% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
HSTC
HST Global, Inc.
this stock
$29.94M — — — 0.0%
VRTX
Vertex Pharmaceuticals Inc
 $138.71B +20.7% +46.2% 35.2 1.7%
MRNA
Moderna, Inc.
 $96.40B +762.0% +4.3% — 8.2%
REGN
Regeneron Pharmaceuticals, Inc.
 $93.82B +17.2% +20.8% 20.1 2.1%
CSLLY
Csl Ltd
 $66.72B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
96
Days to cover
1.0d
Change
+96 sh
View
Short Volume
Short vol %
74%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
694
Value
$486
As of
Sep 28, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 28, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-146.2K
View
Filings
SEC Filings
Latest
10-K
Filed
Nov 3, 2025
This year
0
View

Performance

5D 20D 120D MTD YTD
HSTC +976.9% +12.0% -35.8% +976.9% -29.3%
SPY -1.5% -0.9% +7.7% +0.5% +12.4%
vs SPY +978.4% +12.9% -43.5% +976.4% -41.7%
Key facts CIK 797564 CUSIP 40432E202 Visit website